Pathophysiology of otosclerosis.

R A Chole, M McKenna

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2001;22(2):249-57

PMID: 11300278

Abstract

OBJECTIVE

To review current knowledge of the pathophysiology of otosclerosis and to review hypotheses for the amelioration of this disease.

DATA SOURCES

Review of the literature and experimental observations by the authors.

CONCLUSIONS

Otosclerosis is a localized disease of bone remodeling within the otic capsule of the human temporal bone. Unlike other similar bone diseases, it does not occur outside of the temporal bone. These lesions seem to begin by resorption of stable otic capsule bone in adults, followed by a reparative phase with bone deposition. There are clearly genetic factors that lead to this disease, but measles virus infection and autoimmunity also may play contributing roles. Surgical correction of the conductive hearing loss is highly effective, but nonsurgical intervention has not yet been shown to prevent or slow the disease. Of the factors that may inhibit this process, fluorides, cytokine inhibitors, and bisphosphonates, third-generation bisphosphonates appear to hold the most promise.

Address: Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.